rhenium has been researched along with Pain in 33 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (3.03) | 18.7374 |
1990's | 6 (18.18) | 18.2507 |
2000's | 20 (60.61) | 29.6817 |
2010's | 5 (15.15) | 24.3611 |
2020's | 1 (3.03) | 2.80 |
Authors | Studies |
---|---|
Flux, G; Liepe, K; Murray, I | 1 |
Baziotis, N; Limouris, GS; Zafeirakis, A; Zissimopoulos, A | 1 |
Asavatanabodee, P; Barrenechea, E; Dondi, M; Jeong, MJ; Liepe, K; Padhy, A; Shrikant, S; Soroa, V; Zaknun, JJ | 1 |
Flux, GD; Hindorf, C; Ibisch, C; Kraeber Bodéré, F | 1 |
Baines, L; Buckenmaier, CC; Howard, RS; Radowsky, JS; Shriver, CD; Stojadinovic, A | 1 |
O'Sullivan, JM; Parker, CC; Vengalil, S | 1 |
Douard, MC; George, B; Rain, JD | 1 |
Cheon, GJ; Jeong, JM; Lee, EB; Lee, YJ; Shin, KC; Son, MW; Song, YW | 1 |
Kotzerke, J; Kropp, J; Liepe, K; Runge, R | 1 |
Fuster, D; Pons, F; Vidal-Sicart, S | 1 |
Bandurski, T; Derejko, M; Romanowicz, G; Scheffler, J | 1 |
Chung, JK; Jeong, JM | 1 |
Endo, K; Li, S; Liu, J; Tanada, S; Tian, M; Zhang, H | 1 |
de Klerk, JM; Lam, MG; van Rijk, PP | 1 |
Chen, SX; DU, JQ; Jiang, NY; Liang, JG; Liu, XG; Lu, XP | 1 |
de Klerk, JM; Lambert, B | 1 |
Adams, S; Baum, RP; Breidert-Backes, I; Hör, G | 1 |
Asano, D; Hashimoto, K; Kawashima, H; Kinuya, S; Mori, H; Mukai, T; Ogawa, K; Saji, H; Shiba, K | 1 |
Franklin, S; Hillegonds, DJ; Shelton, DK; Vijayakumar, S; Vijayakumar, V | 1 |
Bender, H; Biersack, HJ; Dierke-Dzierzon, C; Grünwald, F; Mallmann, P; Palmedo, H; Reichmann, K; Schomburg, A; Schöneich, G; Zamorra, P | 1 |
McEwan, AJ | 1 |
Holle, LH; Humke, U; Kirsch, CM; Oberhausen, E; Trampert, L; Ziegler, M | 1 |
Bender, H; Biersack, HJ; Carl, UM; Dierke-Dzierzon, C; Krebs, D; Palmedo, H; Risse, J | 1 |
Csernay, L; Láng, J; Pajor, L; Pávics, L; Róka, R; Séra, T; Thurzó, L | 1 |
Aras, G; Baltaci, S; Bedük, Y; Canakci, N; Ibiş, E; Küçük, NO; Ozalp, G; Soylu, A | 1 |
Franke, WG; Hliscs, R; Koch, R; Kropp, J; Liepe, K; Runge, R | 1 |
Franke, WG; Hliscs, R; Kropp, J; Liepe, K | 1 |
Bestagno, M; Cittanti, C; Colamussi, P; Dafermou, A; Giganti, M; Piffanelli, A | 1 |
Banerjee, S; Chaudhari, PR; Kothari, K; Pillai, MR; Samuel, G; Sarma, HD; Unni, PR; Unnikrishnan, TP | 1 |
Bangard, M; Biersack, HJ; Menzel, C; Palmedo, H; Risse, J; Rockstroh, JK; Schliefer, K | 1 |
Li, S; Liu, J; Tian, M; Wang, J; Zhang, H; Zheng, X | 1 |
Deutsch, EA; Hertzberg, VS; Libson, KF; Maxon, HR; Moulton, JS; Samaratunga, RC; Scher, HI; Schroder, LE; Thomas, SR; Williams, CC | 1 |
Ketring, AR | 1 |
11 review(s) available for rhenium and Pain
Article | Year |
---|---|
Dosimetry of Bone Seeking Beta Emitters for Bone Pain Palliation Metastases.
Topics: Bone and Bones; Bone Neoplasms; Humans; Lutetium; Pain; Radiopharmaceuticals; Rhenium; Tissue Distribution; Zoledronic Acid | 2022 |
Clinical dosimetry in the treatment of bone tumors: old and new agents.
Topics: Bone Neoplasms; Humans; Pain; Palliative Care; Phosphorus Radioisotopes; Radiopharmaceuticals; Radiotherapy Planning, Computer-Assisted; Radium; Rhenium; Samarium; Strontium Radioisotopes; Tin Radioisotopes | 2011 |
Use of radionuclides in metastatic prostate cancer: pain relief and beyond.
Topics: Bone Neoplasms; Humans; Male; Men's Health; Pain; Palliative Care; Prostatic Neoplasms; Radioisotopes; Radium; Rhenium; Samarium; Strontium | 2012 |
[Metabolic radiotherapy: what role will it have in 2001?].
Topics: Adenocarcinoma; Aged; Aged, 80 and over; Analgesics, Opioid; Bone Neoplasms; Clinical Trials as Topic; Double-Blind Method; Forecasting; France; Hematologic Diseases; Humans; Male; Middle Aged; Organometallic Compounds; Organophosphorus Compounds; Pain; Palliative Care; Phosphorus Radioisotopes; Prospective Studies; Prostatic Neoplasms; Radioisotopes; Radiopharmaceuticals; Rhenium; Samarium; Strontium; Strontium Radioisotopes; Treatment Outcome | 2002 |
[Palliative treatment of metastasic bone pain].
Topics: Analgesia; Bone Neoplasms; Contraindications; Drug Costs; Forecasting; Humans; Pain; Palliative Care; Radioisotopes; Radiopharmaceuticals; Rhenium; Samarium; Strontium Radioisotopes; Tin Radioisotopes; Treatment Outcome | 2003 |
Application of rhenium-188 HEDP in bone metastases therapy.
Topics: Bone Neoplasms; Etidronic Acid; Humans; Leukopenia; Organometallic Compounds; Pain; Palliative Care; Practice Patterns, Physicians'; Radiopharmaceuticals; Rhenium; Thrombocytopenia; Treatment Outcome | 2003 |
Therapy with 188Re-labeled radiopharmaceuticals: an overview of promising results from initial clinical trials.
Topics: Antibodies, Monoclonal; Bone Diseases; Clinical Trials as Topic; Coronary Vessels; Iodized Oil; Pain; Radiopharmaceuticals; Rhenium | 2003 |
186Re-HEDP for metastatic bone pain in breast cancer patients.
Topics: Bone Neoplasms; Breast Neoplasms; Dose-Response Relationship, Radiation; Etidronic Acid; Female; Humans; Maximum Tolerated Dose; Organometallic Compounds; Pain; Palliative Care; Radiation Injuries; Radioimmunotherapy; Radiopharmaceuticals; Radiotherapy Dosage; Rhenium; Treatment Outcome | 2004 |
Clinical applications of 188Re-labelled radiopharmaceuticals for radionuclide therapy.
Topics: Arthritis, Rheumatoid; Bone Neoplasms; Graft Occlusion, Vascular; Hematologic Neoplasms; Humans; Pain; Palliative Care; Practice Guidelines as Topic; Practice Patterns, Physicians'; Radioisotopes; Radiopharmaceuticals; Rhenium; Treatment Outcome | 2006 |
The management of painful bone metastases with an emphasis on radionuclide therapy.
Topics: Bone Neoplasms; Combined Modality Therapy; Humans; Neoplasm Metastasis; Pain; Palliative Care; Radioisotopes; Rhenium; Samarium; Strontium Radioisotopes | 2007 |
Unsealed source therapy of painful bone metastases: an update.
Topics: Bone Neoplasms; Clinical Trials as Topic; Etidronic Acid; Female; Humans; Male; Organometallic Compounds; Organophosphorus Compounds; Pain; Pain Management; Palliative Care; Pentetic Acid; Phosphorus Radioisotopes; Radioisotopes; Rhenium; Safety; Strontium Radioisotopes; Syndrome | 1997 |
9 trial(s) available for rhenium and Pain
Article | Year |
---|---|
Radiosynovectomy using yttrium-90, phosphorus-32 or rhenium-188 radiocolloids versus corticoid instillation for rheumatoid arthritis of the knee.
Topics: Adrenal Cortex Hormones; Adult; Aged; Arthritis, Rheumatoid; Colloids; Female; Humans; Instillation, Drug; Knee Joint; Male; Middle Aged; Pain; Phosphorus Radioisotopes; Radiosurgery; Rhenium; Synovial Membrane; Triamcinolone; Yttrium Radioisotopes | 2011 |
Pain ratings by patients and their providers of radionucleotide injection for breast cancer lymphatic mapping.
Topics: Adult; Aged; Aged, 80 and over; Breast Neoplasms; Cohort Studies; Female; Humans; Injections; Lidocaine; Lymph Nodes; Middle Aged; Pain; Pain Measurement; Patients; Physicians; Radionuclide Imaging; Radiopharmaceuticals; Rhenium; Technetium Tc 99m Sulfur Colloid | 2012 |
188Re-tin-colloid as a new therapeutic agent for rheumatoid arthritis.
Topics: Arthritis, Rheumatoid; Female; Humans; Joint Diseases; Knee Joint; Male; Middle Aged; Pain; Radiopharmaceuticals; Rhenium; Tin; Treatment Outcome | 2003 |
Therapeutic efficiency of rhenium-188-HEDP in human prostate cancer skeletal metastases.
Topics: Aged; Aged, 80 and over; Blood Cell Count; Bone Neoplasms; Etidronic Acid; Humans; Male; Middle Aged; Neoplasm Staging; Organometallic Compounds; Pain; Pain Measurement; Prostatic Neoplasms; Radioisotopes; Radionuclide Imaging; Rhenium; Treatment Outcome | 2003 |
[Clinical value of combined therapy with 188Re-HEDP and pamidronate in breast cancer with bone metastasis].
Topics: Adult; Aged; Antineoplastic Agents; Bone Neoplasms; Breast Neoplasms; Carcinoembryonic Antigen; Combined Modality Therapy; Diphosphonates; Etidronic Acid; Female; Follow-Up Studies; Humans; Middle Aged; Organometallic Compounds; Pain; Pain Management; Pamidronate; Radioisotopes; Rhenium | 2005 |
[Pain therapy with rhenium-186 HEDP in multiple bone metastases].
Topics: Bone Neoplasms; Breast Neoplasms; Diphosphonates; Etidronic Acid; Female; Humans; Male; Neoplasm Metastasis; Organometallic Compounds; Organotechnetium Compounds; Pain; Palliative Care; Prostatic Neoplasms; Radioisotopes; Rhenium; Time Factors; Tomography, Emission-Computed | 1996 |
[Clinical experience with rhenium-188 HEDP therapy for metastatic bone pain].
Topics: Alkaline Phosphatase; Analgesics; Bone Neoplasms; Breast Neoplasms; Etidronic Acid; Female; Humans; Male; Pain; Pain Measurement; Prostatic Neoplasms; Radioisotopes; Radionuclide Imaging; Rhenium; Treatment Outcome | 2000 |
[Comparison of rhenium-188, rhenium-186-HEDP and strontium-89 in palliation of painful bone metastases].
Topics: Bone Neoplasms; Breast Neoplasms; Etidronic Acid; Female; Humans; Leukocyte Count; Male; Middle Aged; Organometallic Compounds; Pain; Palliative Care; Platelet Count; Prostatic Neoplasms; Radioisotopes; Rhenium; Strontium Radioisotopes; Tomography, X-Ray Computed | 2000 |
Painful multifocal arthritis: therapy with rhenium 186 hydroxyethylidenediphosphonate ((186)Re HEDP) after failed treatment with medication--initial results of a prospective study.
Topics: Arthritis, Rheumatoid; Etidronic Acid; Female; Humans; Male; Middle Aged; Organometallic Compounds; Pain; Pain Management; Prospective Studies; Radioisotopes; Rhenium; Treatment Failure | 2001 |
13 other study(ies) available for rhenium and Pain
Article | Year |
---|---|
Introduction of a new semi-quantitative index with predictive implications in patients with painful osseous metastases after (186)Re-HEDP therapy.
Topics: Adult; Aged; Aged, 80 and over; Bone Neoplasms; Breast Neoplasms; Etidronic Acid; Female; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Organometallic Compounds; Pain; Pain Measurement; Predictive Value of Tests; Prostatic Neoplasms; Radioisotopes; Radiopharmaceuticals; Rhenium | 2011 |
Rhenium-188-HEDP therapy for the palliation of pain due to osseous metastases in lung cancer patients.
Topics: Adult; Aged; Bone Neoplasms; Dose-Response Relationship, Radiation; Etidronic Acid; Female; Follow-Up Studies; Humans; Leukocyte Count; Lung Neoplasms; Male; Middle Aged; Organometallic Compounds; Pain; Palliative Care; Radionuclide Imaging; Rhenium | 2003 |
[Unusual, unilateral metastasis of a prostate-carcinoma and palliative rhenium-186 pain-therapy].
Topics: Aged, 80 and over; Functional Laterality; Humans; Male; Neoplasm Metastasis; Pain; Prostatic Neoplasms; Radioisotopes; Radionuclide Imaging; Rhenium; Treatment Outcome | 1997 |
Therapeutic effects of a 186Re-complex-conjugated bisphosphonate for the palliation of metastatic bone pain in an animal model.
Topics: Animals; Bone and Bones; Bone Neoplasms; Diphosphonates; Disease Models, Animal; Female; Mammary Neoplasms, Animal; Mice; Neoplasm Metastasis; Organometallic Compounds; Pain; Radioisotopes; Rats; Rats, Sprague-Dawley; Rhenium; Time Factors | 2007 |
[Palliative treatment for pain in osseous metastasized prostatic carcinoma with osteotropic rhenium-186 hydroxyethylidene diphosphonate (HEDP)].
Topics: Aged; Aged, 80 and over; Bone Neoplasms; Diphosphonates; Etidronic Acid; Humans; Male; Middle Aged; Organometallic Compounds; Organotechnetium Compounds; Pain; Palliative Care; Prostatic Neoplasms; Radionuclide Imaging; Radiopharmaceuticals; Radiotherapy; Rhenium | 1997 |
Pain palliation with rhenium-186 HEDP in breast cancer patients with disseminated bone metastases.
Topics: Adult; Aged; Analgesics; Blood Cell Count; Bone Neoplasms; Breast Neoplasms; Etidronic Acid; Female; Humans; Injections, Intravenous; Middle Aged; Pain; Pain Measurement; Palliative Care; Radioisotopes; Radionuclide Imaging; Rhenium; Treatment Outcome | 1999 |
Palliative analgesic effect of Re-186 HEDP in various cancer patients with bone metastases.
Topics: Adult; Aged; Aged, 80 and over; Bone Neoplasms; Breast Neoplasms; Etidronic Acid; Female; Humans; Lung Neoplasms; Male; Middle Aged; Nasopharyngeal Neoplasms; Organometallic Compounds; Pain; Palliative Care; Prostatic Neoplasms; Radiopharmaceuticals; Rectal Neoplasms; Rhenium | 2000 |
Significant reduction of the mass of bone metastasis 1 year after rhenium-186 HEDP pain palliation therapy.
Topics: Bone Neoplasms; Etidronic Acid; Humans; Male; Middle Aged; Organometallic Compounds; Pain; Palliative Care; Prostatic Neoplasms; Radioisotopes; Radionuclide Imaging; Radiopharmaceuticals; Rhenium; Technetium Tc 99m Medronate | 2000 |
A multicentre observational study of radionuclide therapy in patients with painful bone metastases of prostate cancer.
Topics: Aged; Aged, 80 and over; Bone Neoplasms; Etidronic Acid; Humans; Injections, Intravenous; Male; Middle Aged; Organometallic Compounds; Pain; Pain Measurement; Palliative Care; Prostatic Neoplasms; Radionuclide Imaging; Radiopharmaceuticals; Rhenium; Strontium; Strontium Radioisotopes | 2001 |
186Re-1,4,8,11-tetraaza cyclotetradecyl-1,4,8,11-tetramethylene phosphonic acid: a novel agent for possible use in metastatic bone-pain palliation.
Topics: Analgesics; Animals; Bone Neoplasms; Etidronic Acid; Heterocyclic Compounds, 1-Ring; Injections, Intravenous; Male; Organometallic Compounds; Organophosphonates; Pain; Rabbits; Rats; Rats, Sprague-Dawley; Rhenium; Tissue Distribution | 2001 |
Rhenium-188 HEDP to treat painful bone metastases.
Topics: Bone Neoplasms; Etidronic Acid; Female; Follow-Up Studies; Humans; Leukocyte Count; Male; Middle Aged; Organometallic Compounds; Pain; Pain Management; Palliative Care; Platelet Count; Radionuclide Imaging; Radiopharmaceuticals; Rhenium | 2001 |
Re-186(Sn) HEDP for treatment of painful osseous metastases: initial clinical experience in 20 patients with hormone-resistant prostate cancer.
Topics: Adenocarcinoma; Aged; Bone Neoplasms; Estrogens; Etidronic Acid; Humans; Male; Organometallic Compounds; Pain; Palliative Care; Prostatic Neoplasms; Quality of Life; Radioisotopes; Radiotherapy Dosage; Rhenium; Tin | 1990 |
153Sm-EDTMP and 186Re-HEDP as bone therapeutic radiopharmaceuticals.
Topics: Animals; Bone Neoplasms; Dogs; Etidronic Acid; Humans; Kinetics; Organophosphorus Compounds; Pain; Rabbits; Radioisotopes; Radionuclide Imaging; Rhenium; Samarium; Technetium Tc 99m Medronate; Tissue Distribution | 1987 |